Shares of Evolent Health (EVH) were up over 8% or to approximately $31 per share in late day trading on Thursday after announcing it has expanded its partnership with Humana (HUM) in a slides presentation prepared for the JP Morgan Healthcare conference.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on EVH:
- Evolent Health price target raised to $51 from $44 at Piper Sandler
- Evolent Health management to meet with BTIG
- Evolent Health price target raised to $44 from $33 at Piper Sandler
- EVOLENT HEALTH ANNOUNCES ACQUISITION OF SPECIALTY ASSET NIA AND STRATEGIC PARTNERSHIP WITH CENTENE
- Evolent Health participates in a conference call with Truist